Paradigm Biocapital Advisors LP - 31 Dec 2025 SCHEDULE 13G/A Report for Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share (EWTX)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
EWTX
Shares outstanding
105,503,387 shares
Disclosed Ownership
6,541,210 shares
Ownership
6.2%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:02:54 UTC
Date of event
31 Dec 2025
Previous filing
03 Feb 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 6.2% 6,541,210 6,541,210 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 6.2% 6,541,210 6,541,210 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 6.2% 6,541,210 6,541,210 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 5.5% 5,778,924 5,778,924 0 /s/ David K. Kim David K. Kim / Authorized Signatory